lactams 12c and 13c (total 210 mg, 54%), ratio 62 : 38 by 1H NMR
spectroscopy.
6.8; N, 5.0. C19H19NO2 requires C, 77.79; H, 6.53; N, 4.77%); [a]D23
−183 7 (c 1.9, CHCl3); mmax/cm−1 3068, 2959, 2885, 1639, 1600,
1449, 1406, 1289, 1216, 1173, 1080, 854; dC (75 MHz, CDCl3) 16.5
(MeA), 19.8 (MeB), 28.0 (CHMe2), 61.9 (7-C), 67.2 (6-C), 86.6
(4b-C), 122.3, 128.4 (two), 129.2, 129.4, 130.0, 130.2 and 131.4
(ArCH), 135.7, 136.2, 136.6 and 139.0 (quaternary ArC), 164.5
(8-C); m/z 609 ([2M + Na]+, 100%), 357 (79), 294 ([M + H]+, 82);
Rf 0.30 (EtOAc–hexane, 1 : 4). Mixed fractions were condensed to
give an oil (139 mg, 38%) which was purified by preparative TLC
[20 × 20 × 0.02 cm (Merck 1.05583); multiple elution with EtOAc–
hexane 1 : 6], giving 12a (95 mg, 26%) and the title compound
13a (42 mg, 11.5%), m.p. 114–115 ◦C (petroleum, b.p. 60–80 ◦C)
(Found: C, 78.0; H, 6.8; N, 5.0. C19H19NO2 requires C, 77.79; H,
6.53; N, 4.77%); [a]D27 +148 5 (c 2.25, CHCl3); mmax/cm−1 3064,
2959, 2874, 1639, 1596, 1445, 1402, 1344, 1169, 1080, 994, 963,
858, 742, 703; dC (75 MHz, CDCl3) 18.7 (Me), 19.7 (Me), 30.7
(CHMe2), 63.0 (7-C), 69.5 (6-C), 86.1 (4b-C), 122.5, 128.3, 128.4,
129.1, 129.7, 130.3, 130.7 and 131.8 (ArCH), 134.1, 136.2, 137.6
and 139.3 (quaternary ArC), 165.4 (8-C); m/z 609 ([2M + Na]+,
100%), 357 (88), 294 ([M + H]+, 81); Rf 0.28 (EtOAc–hexane,
1 : 4).
Method B. Heating the ester-aldehyde 9 (110 mg, 0.46 mmol)
and (S)-phenylalaninol 11c (104 mg, 0.69 mmol) in xylene (5 mL)
at 155 ◦C (bath temp.) for 3 d followed by removal of the
solvent in vacuo gave a mixture of isomeric lactams (ratio 92 :
8). Chromatography (EtOAc–hexane, 15 : 85) gave the title
compound 12c (129 mg, 83%) as a colourless solid, m.p. 84–
84.5 ◦C (dichloromethane) (Found: C, 80.75; H, 5.67; N, 4.03.
C23H19NO2 requires C, 80.92; H, 5.61; N, 4.10%); [a]2D6 −226
9
(c 1.0, CHCl3); mmax/cm−1 3069, 2927, 1638, 1447, 1406, 750; dC
(100 MHz, CDCl3) 37.0 (PhCH2), 58.2 (7-C), 69.4 (6-C), 86.0 (4b-
C), 121.7, 126.7, 128.13, 128.15, 128.7 (two), 128.9, 129.4, 129.6
(two), 129.9, 130.0 and 131.3 (ArCH), 134.8, 136.1, 136.2, 137.9
and 138.4 (quaternary ArC), 163.9 (8-C); m/z 705 ([2M + Na]+,
46%), 405 ([M + 2Na + H2O]+, 69), 364 ([M + Na]+, 100), 342 ([M +
H]+, 82) (Found: M, 341.1416; C23H19O2N requires 341.1410); Rf
0.38 (EtOAc–hexane, 3 : 7). Further elution of the column yielded
a mixed fraction (11 mg, 7%) and the title compound 13c (9 mg,
6%) as a colourless oil; mmax/cm−1 2913, 2844, 1642, 1448, 1081;
dC (100 MHz, CDCl3) 38.5 (CH2Ph), 58.5 (7-C), 70.5 (6-C), 85.8
(4b-C), 121.9, 126.7, 128.2, 128.4, 128.7 (two), 128.9, 129.5 (two),
129.6, 129.8, 130.2 and 131.5 (ArCH), 133.9, 135.9, 137.2, 137.8
and 139.4 (quaternary ArC), 164.2 (8-C); m/z 705 ([2M + Na]+,
11%), 405 ([M + 2Na + H2O]+, 47), 364 ([M + Na]+, 96), 342 ([M +
H]+, 100) (Found: M, 341.1412; C23H19O2N requires 341.1410); Rf
0.31 (EtOAc–hexane, 3 : 7).
From ester 9. Heating the ester-aldehyde
9 (230 mg,
0.96 mmol) and (S)-valinol 11a (148 mg, 1.43 mmol) in toluene
(15 mL) under reflux (bath temp. 120 ◦C) for 7 d gave the mixed
lactams 12a and 13a (total 200 mg, 71%, ratio 96 : 4).
(aS,4bR,7S)-6,7-Dihydro-7-phenyldibenz[c,e]oxazolo[3,2-
a]azepin-9(4bH)-one 12b and (aR,4bS,7S)-6,7-dihydro-7-
phenyldibenz[c,e]oxazolo[3,2-a]azepin-9(4bH)-one 13b
(aS,4bR,7S)-6,7-Dihydro-7-methyldibenz[c,e]oxazolo[3,2-
a]azepin-9(4bH)-one 12d and (aR,4bS,7S)-6,7-dihydro-7-
methyldibenz[c,e]oxazolo[3,2-a]azepin-9(4bH)-one 13d
Method A. Heating the acid-aldehyde 7 (296 mg, 1.31 mmol)
and the amino alcohol 11b (270 mg, 1.97 mmol) in toluene (15 mL)
under reflux (bath temp. 120 ◦C) for 36 h gave the mixed lactams
12b and 13b (total 320 mg, 75%, ratio 70 : 30).
Method A. Heating the acid-aldehyde 7 (290 mg, 1.28 mmol)
and (S)-2-amino-1-propanol 11d (144 mg, 1.92 mmol) in toluene
(15 mL) under reflux (bath temp. 120 ◦C) for 36 h gave the mixed
lactams 12d and 13d (total 200 mg, 59%), ratio 56 : 44 by 1H NMR
spectroscopy.
Method B. Heating the ester-aldehyde 9 (100 mg, 0.42 mmol)
and (S)-phenylglycinol 11b (86 mg, 0.63 mmol) in xylene (5 mL)
at 155 ◦C (bath temp.) for 3 d followed by removal of the
solvent in vacuo gave a mixture of isomeric lactams (ratio 91 : 9).
Chromatography (EtOAc–hexane, 1 : 4) gave the title compound
12b (120 mg, 88%) as colourless needles, m.p. 143–145 ◦C (MeOH)
(lit.13 138–140 ◦C); [a]D28 −86 8 (c 0.26, CHCl3); mmax/cm−1 3662,
3471, 3269, 3067, 3021, 2948, 2889, 1638, 1452, 1398, 1339, 1277,
1211, 1157, 904, 737; dC (100 MHz, CDCl3) 60.2 (6-C), 74.0 (7-C),
86.6 (4b-C), 121.8, 126.3 (two), 127.8, 128.2 (two), 128.8 (two),
129.1, 129.4, 130.0, 130.2 and 131.4 (ArCH), 134.8, 136.2, 136.4,
138.3 and 140.8 (quaternary ArC), 163.7 (8-C); m/z 677 ([2M +
Na]+, 49), 510 (53), 391 ([M + 2Na + H2O]+, 58), 355 (100),
350 ([M + Na]+, 82), 329 (76), 235 (73), 207 (38) (Found: M +
Na, 350.1145; C22H17O2NNa requires 350.1152); Rf 0.25 (EtOAc–
hexane, 3 : 7).
Method B. Heating the ester-aldehyde 9 (95 mg, 0.40 mmol)
and (S)-2-amino-1-propanol 11d (45 mg, 0.60 mmol) in xylene
(5 mL) at 155 ◦C (bath temp.) for 3 d followed by removal of the
solvent in vacuo gave a mixture of isomeric lactams (ratio 85 : 15).
Chromatography (EtOAc–hexane, 15 : 85) gave the title compound
12d (76 mg, 72%) as a colourless oil; [a]2D9 −143 7 (c 3.6, CHCl3);
mmax/cm−1 3065, 2975, 2887, 1638, 1451, 1410, 1217, 940, 912, 748,
730; dC (100 MHz, CDCl3) 18.3 (Me), 52.7 (7-C), 72.8 (6-C), 85.7
(4b-C), 121.7, 128.1 (two), 128.9, 129.4, 129.9, 130.0 and 131.1
(ArCH), 134.9, 136.17, 136.20 and 138.5 (quaternary ArC), 163.7
(8-C); m/z 266 ([M + H]+, 100%) (Found: M + H, 266.1165;
C17H16O2N requires 266.1176); Rf 0.20 (EtOAc–hexane, 3 : 7).
Further elution of the column yielded a mixed fraction (17 mg,
16%) and a fraction enriched in the minor isomer 13d (10 mg,
1
10%, ca. 80% d.e. by H NMR spectroscopy) as a colourless oil;
(aS,4bR,7S)-6,7-Dihydro-7-(phenylmethyl)dibenz[c,e]oxazolo[3,2-
a]azepin-9(4bH)-one 12c and (aR,4bS,7S)-6,7-dihydro-7-
(phenylmethyl)dibenz[c,e]oxazolo[3,2-a]azepin-9(4bH)-one 13c
mmax/cm−1 2964, 2923, 2912, 2841, 1632, 1463, 1407, 1094, 741; dC
(75 MHz, CDCl3) 19.1 (Me), 52.9 (7-C), 73.7 (6-C), 85.7 (4b-C),
121.7, 128.2, 128.3, 128.9, 129.7, 129.8, 130.2 and 131.5 (ArCH),
134.1, 135.9, 137.1 and 139.8 (quaternary ArC), 163.6 (8-C); m/z
266 ([M + H]+, 100%) (Found: M + H, 266.1181; C17H16O2N
requires 266.1176); Rf 0.14 (EtOAc–hexane, 3 : 7).
Method A. Heating the acid-aldehyde 7 (260 mg, 1.15 mmol)
and (S)-phenylalaninol 11c (260 mg, 1.72 mmol) in toluene
(15 mL) under reflux (bath temp. 120 ◦C) for 36 h gave the mixed
2666 | Org. Biomol. Chem., 2007, 5, 2658–2669
This journal is
The Royal Society of Chemistry 2007
©